Research On Tobacco And The Coronavirus – CSUR 2021


Posted June 27, 2021 by csuresuk

CSUR Provide Information On Research On Tobacco And The Coronavirus In 2021
 
During the current coronavirus pandemic, you may have read stories suggesting that smokers are less likely to get coronavirus, while other stories claim that that smoking increases the severity of the coronavirus if you catch it. There is still a lot of evidence emerging on how smoking and the COVID-19 virus are linked, based on the damaging effects of smoking outweighing any potential benefits.

The World Health Organization (WHO) identified that smoking is associated with the risk of a more severe illness and the risk of death is also increased when linked to the coronavirus. It also identified that smokers were more likely to need hospital treatment. Studies have identified that smokers who get the virus are more likely to need hospital treatment to manage their symptoms, while non-smokers were more likely to manage their symptoms at home.

A Research Fellow at CSUR (Centre for substance Use Research Ltd), Sophie Dotley said “Smoking already puts you at a higher risk of developing some very serious health conditions including lung disease, diabetes, and cardiovascular disease. We know that people that have underlying health conditions are more likely to be hospitalised if they get the coronavirus, along with an increased mortality rate. By not smoking, you reduce the risk of severe illness caused by the current coronavirus.”

There is no direct link to provide that smoker are more likely to catch the COVID-19 virus, but if they do, the chances of them becoming seriously ill are increased, compared to non-smokers. One of the ways your risk of getting the virus can be increased when smoking is that smokers are more likely to touch their face and mouth more often than those that don't smoke.

Another study found that those that smoke may be less likely to get the virus because nicotine can interfere with the ACE2 receptors, preventing the virus from getting into the cells. More scientific research is needed to understand which is correct. Some papers state that there is no direct link, while others believe that due to the coronavirus attacking the lungs, smokers may be unable to fight off the infection, unlike non-smokers who have healthy lungs.

About Us:
Centre for Substance Use Research Ltd (CSUR) is a global leader in behavioral sciences in tobacco harm reduction and ENDS regulations. Based in Glasgow, Scotland, and backed by years of experience, this company is a multi-disciplinary research agency that helps with the submission of applications for PMTA, MRTP, and TDE approval. They also register for approval for ENDS companies. CSUR carries out laboratory, clinical, and behaviour studies with research programs, design, analytical services, along with a presentation of findings. The agency has been operating since 1994 and became independent in 2011. Full details can be found at https://www.csures.com.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Centre for Substance Use Research (CSUR)
Phone 44 141 946 6392
Business Address 4 Woodside Terrace, Lanarkshire, United Kingdom, G3 7UY
Country United Kingdom
Categories Science
Tags harm reduction approaches , modified risk tobacco products , mrtp
Last Updated June 27, 2021